Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyde Advisory & Investments is a private advisory and brokerage firm focused on the global cannabis sector rather than a drug-development biotech company. The firm provides mergers and acquisitions advisory, strategic investment and partnership support, joint venture facilitation, divestitures, and pre-acquisition due diligence for licensed cannabis businesses and related stakeholders. It also advises companies and governments on licensing strategy, regulatory matters, facility design and operations, corporate governance, and international supply chain matters, including EU-GMP-related export and sourcing activities. The company appears to operate as a specialized services business serving cultivators, processors, testing and research labs, retailers, and market entrants across multiple countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyde Advisory & Investments.